Black-blood T2* technique for myocardial iron measurement in thalassemia

Journal of Magnetic Resonance Imaging

Volumn 25, Issue 6, 2007, Pages 1205-1209

  He, Taigang ^a   Gatehouse, Peter D ^a   Kirk, Paul ^a   Tanner, Mark A ^a   Smith, Gillian C ^a   Keegan, Jennifer ^a   Mohiaddin, Raad H ^a   Pennell, Dudley J ^a,b   Firmin, David N ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b Cardiovascular Imaging Solutions

Author keywords

Black blood imaging; CMR; Iron overload; Myocardial T2*; Thalassemia

Indexed keywords

IRON;

ADULT; ARTICLE; CLINICAL ARTICLE; DIASTOLE; FEMALE; HEART MUSCLE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MEASUREMENT; PRIORITY JOURNAL; REPRODUCIBILITY; SYSTOLE; TECHNIQUE; THALASSEMIA;

ADULT; DIASTOLE; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; REPRODUCIBILITY OF RESULTS; THALASSEMIA;

EID: 34249863293     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20929     Document Type: Article

References (15)

1. Brittenham GM, Badman DG. Noninvasive measurement of iron: report of an N1DDK workshop. Blood 2003;101:15-19.
2. Pennell DJ. T2* Magnetic resonance and myocardial iron in thalassemia. Ann NY Acad Sci 2005;1054:373-378.
3. Anderson LJ, Holden S, Davies B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
4. Tanner MA, Galanello R, Dessi C, et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006;8:543-547.
5. Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003;18:33-39.
6. Westwood MA, Anderson LJ, Firmin DN, et al. lnterscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging 2003;18:616-620.
7. Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004;103:1934-1936.
8. Wood JC, Otto-Duessel M, Aguilar M, et al. Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005;112:535-543.
9. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron levels and ventricular function in beta thalassemia. Lancet 2002;360:516-520.
10. Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 2004;127:348-355.
11. Pennell DJ, Berdoukas V, Karagiorga M, et al. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 2006;107:3738-3744.
12. Anderson LJ, Westwood MA, Prescott E, Walker JM, Pennell DJ, Wonke B. Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine. Acta Haematol 2006;115:106-108.
13. Felmlee JP, Ehman RL. Spatial presaturation: a method for suppressing flow artifacts and improving depiction of vascular anatomy in MR imaging. Radiology 1987;164:559-564.
14. Simonetti OP, Finn JP, White RD, et al. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology 1996;199:49-57.
15. Ghugre NR, Enriquez CM, Coates TD, Nelson Jr MD, Wood JC. Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 2006;23:9-16.